KIRSTEN BUBB: Open Payments
NPI 1134554751 · LOCK HAVEN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,242 in 131 payments from 17 companies in 2025. Trend: 2023 $768 · 2024 $818 · 2025 $2,242
Food & beverage: $2,242
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 28 | $490 |
| ABBVIE INC. | 26 | $410 |
| Exact Sciences Corporation | 12 | $248 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $190 |
| AstraZeneca Pharmaceuticals LP | 8 | $145 |
| Lilly USA, LLC | 9 | $140 |
| Amgen Inc. | 6 | $94 |
| Dexcom, Inc. | 4 | $83 |
| PFIZER INC. | 5 | $78 |
| GlaxoSmithKline, LLC. | 5 | $77 |
Products named: Ozempic, Cologuard Collection Kit, VRAYLAR, CAPLYTA, Wegovy, AIRSUPRA, MOUNJARO, QULIPTA.
Industry payments across PA — which companies pay providers there.
